Moderna (MRNA)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Moderna (MRNA)
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Key Insights
Critical company metrics and information
Share Price
$41.86Market Cap
$16.11 BillionTotal Outstanding Shares
384.82 Million SharesTotal Employees
5,600Dividend
No dividendIPO Date
December 7, 2018SIC Description
Biological Products, (no Disgnostic Substances)Homepage
https://www.modernatx.com
Historical Stock Splits
If you bought 1 share of MRNA before July 22, 2010, you'd have 0.00 shares today.
| Execution Date | Split Amount |
|---|---|
| August 3, 2017 | 1-for-10 (Reverse Split) |
| December 23, 2011 | 1-for-10 (Reverse Split) |
| July 22, 2010 | 1-for-4 (Reverse Split) |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-1.31 Billion |
| Net Cash Flow From Investing Activities | $1.95 Billion |
| Net Cash Flow From Operating Activities | $-3.21 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-50.00 Million |
| Net Cash Flow From Investing Activities, Continuing | $1.95 Billion |
| Net Cash Flow From Operating Activities, Continuing | $-3.21 Billion |
| Net Cash Flow From Financing Activities | $-50.00 Million |
| Net Cash Flow, Continuing | $-1.31 Billion |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $-2.22 Billion |
| Diluted Earnings Per Share | $5.82 |
| Gross Profit | $3.43 Billion |
| Research and Development | $4.83 Billion |
| Operating Income/Loss | $-2.69 Billion |
| Basic Earnings Per Share | $5.82 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Net Income/Loss | $-2.22 Billion |
| Revenues | $5.08 Billion |
| Income/Loss From Equity Method Investments | $-62.00 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Benefits Costs and Expenses | $7.43 Billion |
| Income Tax Expense/Benefit | $-129.00 Million |
| Costs And Expenses | $7.77 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $-2.22 Billion |
| Cost Of Revenue | $1.65 Billion |
| Income/Loss From Continuing Operations Before Tax | $-2.35 Billion |
| Net Income/Loss Attributable To Parent | $-2.22 Billion |
| Diluted Average Shares | $782.00 Million |
| Other Operating Expenses | $1.29 Billion |
| Income/Loss Before Equity Method Investments | $-2.29 Billion |
| Basic Average Shares | $768.00 Million |
| Operating Expenses | $6.12 Billion |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Inventory | $412.00 Million |
| Noncurrent Assets | $6.14 Billion |
| Current Liabilities | $2.20 Billion |
| Other Current Liabilities | $1.58 Billion |
| Other Current Assets | $9.25 Billion |
| Assets | $15.80 Billion |
| Noncurrent Liabilities | $1.68 Billion |
| Liabilities | $3.88 Billion |
| Wages | $244.00 Million |
| Equity | $11.93 Billion |
| Liabilities And Equity | $15.80 Billion |
| Equity Attributable To Parent | $11.93 Billion |
| Accounts Payable | $373.00 Million |
| Current Assets | $9.67 Billion |
| Equity Attributable To Noncontrolling Interest | $0.00 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.